
### Date
What was the date of the study?

### Study
What was the name of the study?
What was the title?

### Study Link
URL for the study?
What is the link for the publication?


### Journal
What was the Journal at which study was published?


### Study type?
What was the type of the study?
Was it a Meta-Analysis study?
Was it a Systematic Review study?
Was it a Randomized Controlled Trial?
Was it a Cohort Study (Prospective Observational Study)?
Was it a Case-control Study?
Was it a Cross-sectional study?
Was it a Case Reports and Series study?



### Therapeutic method(s) utilized/assessed
What therapeutic method was utilized?
What was the treatment of thrombosis?
--Effect of heparin?
--Effect of Tissue plasminogen activator
--direct oral anticoagulants (DOACs)
-- prophylactic anticoagulation 
What was the does of the treatment?
What is the optimal dosing?
What was the frequency of treatments?
What was the result of treatment?
What were all the interventions?
Was the paitent on antiviral drug? 

###Sample
how many cases were there? 
How many control cases were there?
Demographics of patients
Did the patient has the stroke background?

## Sample and Severity of Symptoms
What was the clot formation time?
What was the Maximum Clot Firmness?
What is the D-dimer values?
What is the prothrombin time?
What was the Platelet count?
What was the type of the Coagulopathy?
--Was it Disseminated Intravascular Coagulation?
--Was it Thrombotic microangiopathy?
What was the Thrombotic manifestations?
--Venous thromboembolic disease
--Arterial thrombosis


### Severity of Symptoms
What was the severity of symptoms?
Severity of COVID-19?
Were there any organ failure?
What was the Kirby index?
Was the patient using mechanical ventilator?
Was the patient in ICU?
Was the patient admitted to intensive care unit?
How was the CT scan score?
What was the severity of lung infection?


### General Outcome/Conclusion 
DOAC plasma levels before and after the treatment
improvement in ventilatory parameters
improvement in oxygenation
D-Dimer or SIC score after treatment
difference between treatment and control group
What was the survival rate?
How many patients were discharge from hospital?
How many days they stayed at the hospital?
How many days after the treatment patients were discharged from hospital?

### Conclusion, Excerpt Primary Endpoint(s) of Study Clinical Improvement (Y/N)
Which patient types develop thrombotic event?
What is considered a  thrombotic implication caused by COVID-19?
Which Covid-19 patients are at a higher risk of developing thrombosis risk?
What drug is recommended for the patients with mild symptoms to prevent thrombotic implication?
What drug is recommend for non-ICU patient at hospital?
What drug or treatment strategy is recommended for ICU patient?
What is the best drug/treatment with patients who have a stroke background ?
What is the best drug/treatment with patients who have background of coagulation?




